- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Arbios Systems Inc
+ Add to WatchlistARBI:US
0.0010 USD 0.00000.00%As of 20:10:00 ET on 04/09/2013.
Snapshot for Arbios Systems Inc (ARBI)
| Open: | - | Day's Range: | - | Volume: | 3,202 |
|---|---|---|---|---|---|
| Previous Close: | 0.0010 | 52wk Range: | 0.0010 - 0.0150 | 1-Yr Rtn: | - |
Key Statistics for ARBI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ARBI
No data available
Company Profile & Key Executives for ARBI
Arbios Systems, Inc. develops, manufactures, and markets liver assist devices to meet the need for therapy of liver failure. The Company's products include a blood purification therapy that provides liver dialysis and a bioartificial liver that combines blood detoxification with liver cell therapy to replace whole liver function in patients with the most severe forms of liver failure.
More Company Profile & Key Executives for ARBIQuotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ARBI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page